Katherine Stueland, CEO: GeneDx Holdings WGS Sell · Filed 25/10/01

Trade details

Type: Insider sale
Amount: $560,443.65
Shares · price: 5,163 sh · $108.55 a share
Held after: 3,255 sh
Stock: GeneDx Holdings WGS
Person: Katherine StuelandCEO
Trade date: 25/09/30
Filed: 25/10/01
Days to filing: 1 days

Sold 61.3% of holdings

Share of holding sold: 61.3%

GeneDx Holdings trades, last 26 weeks

What else happened in GeneDx Holdings around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Katherine Stueland's recent trades

Katherine StuelandCEO
Planned saleGeneDx Holdings
Planned sale
GeneDx Holdings
WGS
$1.2M
14,243 sh
$1.2M
Filed 09/01
Traded 09/09
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$360.8K
5,932 sh
$360.8K
Filed 06/18
Traded 06/16
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$149.4K
2,429 sh
$149.4K
Filed 06/18
Traded 06/16
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$127.9K
2,140 sh
$127.9K
Filed 06/18
Traded 06/16
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$195.7K
3,639 sh
$195.7K
Filed 06/11
Traded 06/09

Katherine Stueland, CEO — sold $560.4K of GeneDx Holdings WGS · 61.3% of holdings · 10b5-1 plan | Whalegun